Beth Rogozinski

Beth Rogozinski serves as the Chief Executive Officer of Oncoustics, where advanced AI solutions for low-cost, non-invasive disease surveillance, diagnostics, and treatment monitoring are developed. With experience as an Independent Board Director at UnitedHealth Group and several other organizations, Rogozinski plays an advisory role in various healthcare initiatives, focusing on digital medicine and dementia care transformation through leadership positions at organizations including Mentia, Inc., Koa Health, and Neolth Inc. Additionally, as a Senior Advisor at the National Mental Health Innovation Center and an advisor/mentor at the UCSF Entrepreneurship Center, Rogozinski supports healthcare innovation and entrepreneurship. Educational credentials include an MBA in Marketing and Management from San Francisco State University.